News

Pyxis Oncology, Inc. (Nasdaq: PYXS), a clinical-stage company developing next-generation antibody-drug conjugate ('ADC') ...
Cohen Circle Acquisition Corp. II (NASDAQ:CCIIU) (the "Company") today announced the pricing of its initial public offering of 22,000,000 units at ...